Skip to Content

G248 150 (Fenofibrate 150 mg)

Pill with imprint G248 150 is White, Capsule-shape and has been identified as Fenofibrate 150 mg. It is supplied by H2-Pharma, LLC.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G248 150

Fenofibrate 150 mg G248 150

Fenofibrate

Imprint
G248 150
Strength
150 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
H2-Pharma, LLC

Labelers / Repackagers

NDC CodeLabeler / Repackager
61269-0212
66869-0147 Kowa Pharmaceuticals America, Inc.

Get help with Imprint Code FAQs.

Related Images for "G248 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.